Home > Insider Trading > Filing (0001104659-19-039864)

Filing Details

Accession Number:: 0001104659-19-039864
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-10 21:56:35
Reporting Period:: 2019-07-08

Accepted Time:: 2019-07-10 21:56:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1633070	Axcella Health Inc.	AXLA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1445826	R David Epstein	C/O Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-07-08	274	$9.00	24,830	No	4	P	Direct
Common Stock	Acquisiton	2019-07-09	4,200	$8.24	29,030	No	4	P	Direct
Common Stock	Acquisiton	2019-07-10	1,322	$8.07	30,352	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.77 to $9.09, inclusive. The reporting person undertakes to provide to Axcella Health Inc., any security holder of Axcella Health Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The amount of securities beneficially owned following reported transaction(s) accurately reports the beneficial ownership total following the purchase made on 7/8/2019. The total amounts reported on on the Form 4 filed on 7/3/2019 were incorrect, and should have read 21,000, 24,500 and 24,556, respectively as opposed to 15,500, 19,000 and 19,056.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.15 to $8.52, inclusive. The reporting person undertakes to provide to Axcella Health Inc., any security holder of Axcella Health Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.05 to $8.32, inclusive. The reporting person undertakes to provide to Axcella Health Inc., any security holder of Axcella Health Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.